Savilova A M, Farkhat K N, Yushina M N, Rudimova Yu V, Makiyan Z N, Adamyan L V
V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation, Moscow, Russia.
Bull Exp Biol Med. 2017 Feb;162(4):539-544. doi: 10.1007/s10517-017-3656-7. Epub 2017 Feb 27.
We isolated and characterized cell cultures from eutopic endometrium and endometriotic lesions of women with malformations of the internal reproductive organs. The cells had fibroblast-like shape and intensively expressed CD90, CD73, CD105, CD44, CD146, and CD117 and were capable of induced adipogenic and osteogenic differentiation in vitro. The obtained cultures exhibited properties of multipotent mesenchymal stromal cells; at the same time, they demonstrated in vitro immunophenotypic differences from cell cultures of eutopic and ectopic endometrium of women without developmental abnormalities, which suggests their functional difference. The cells from eutopic endometrium and from ectopic endometriotic lesions can be used as the model for studying of the etiology and pathogenesis of endometriosis and for testing new drugs for this specific group of patients. Markers CD90 and CD117 were identified as promising molecules for the development of minimally invasive diagnostics of endometriosis based on cell cultures from eutopic endometrium.
我们从患有内生殖器官畸形的女性的在位内膜和子宫内膜异位症病变中分离并鉴定了细胞培养物。这些细胞呈成纤维细胞样形态,强烈表达CD90、CD73、CD105、CD44、CD146和CD117,并且能够在体外诱导脂肪生成和成骨分化。所获得的培养物表现出多能间充质基质细胞的特性;同时,它们在体外表现出与无发育异常女性的在位和异位内膜细胞培养物的免疫表型差异,这表明它们的功能差异。来自在位内膜和异位子宫内膜异位症病变的细胞可作为研究子宫内膜异位症病因和发病机制以及为该特定患者群体测试新药的模型。标记物CD90和CD117被确定为基于在位内膜细胞培养物开发子宫内膜异位症微创诊断的有前景的分子。